Showing posts with label
ViiV Healthcare
.
Show all posts
Showing posts with label
ViiV Healthcare
.
Show all posts
Tuesday, January 12, 2016
ViiV Healthcare to Progress Collaboration with Janssen to Develop the First Long-acting, Two Drug Injectable Regimen for Treatment of HIV-1 Infection
›
ViiV Healthcare, a global specialist HIV company with GSK, Pfizer Inc. and Shionogi Limited as shareholders, today formalised its ...
Monday, September 28, 2015
New Phase IIIb/IV Data Show Switching to Once-Daily Triumeq(R) Maintains HIV Viral Suppression
›
ViiV Healthcare today announced 24-week data from the Phase IIIb/IV STRIIVING study, an open-label study evaluating the efficacy, ...
›
Home
View web version
